XML 26 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity and Stock-Based Compensation
6 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Equity and Stock-Based Compensation

9. Equity and Stock-Based Compensation

 

Stock-based compensation expense was $0.3 million and $0.2 million in the three months ended March 31, 2024 and 2023, respectively, and $0.7 million and $0.3 million in the six months ended March 31, 2024 and 2023, respectively. Stock-based compensation expense is included in selling, general and administrative expenses.

 

The following table summarizes our stock option activity during the six months ended March 31, 2024:

 

 

 

Options

 

 

Weighted
Average
Exercise Price

 

Outstanding at beginning of period

 

 

672,924

 

 

$

8.76

 

Granted

 

 

557,500

 

 

 

5.66

 

Exercised

 

 

(5,000

)

 

 

5.67

 

Forfeited

 

 

(43,991

)

 

 

9.63

 

Outstanding at end of period

 

 

1,181,433

 

 

$

7.28

 

Exercisable at end of period

 

 

424,643

 

 

$

8.49

 

Weighted average fair value of options granted during the period

 

$

2.44

 

 

 

 

 

The fair value of options was estimated at the applicable grant date using the Black-Scholes option pricing model with the following assumptions:

 

 

 

Six Months Ended March 31,

 

 

 

2024

 

 

2023

 

Risk free interest rate

 

 

4

%

 

 

4

%

Expected term

 

5 years

 

 

5 years

 

Dividend rate

 

 

%

 

 

%

Volatility

 

 

60

%

 

 

56

%

 

 

The following table summarizes our RSU activity during the six months ended March 31, 2024:

 

 

 

Number

 

 

Weighted
Average
Grant Date
Fair Value

 

Nonvested at beginning of year

 

 

75,977

 

 

$

9.15

 

Granted

 

 

24,897

 

 

 

4.82

 

Released

 

 

(20,421

)

 

 

9.55

 

Forfeited

 

 

 

 

 

 

Nonvested at end of period

 

 

80,453

 

 

$

7.71

 

 

2023 Stock Repurchase Plan

 

On February 7, 2023, our Board of Directors (the “Board”) approved a stock repurchase program, pursuant to which we may repurchase up to $5 million of our outstanding Common Stock over a one-year period, commencing on February 10, 2023. Repurchases under the program will be made in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in compliance with the rules and regulations of the Securities and Exchange Commission; however, we have no obligation to repurchase shares and the timing, actual number, and value of shares to be repurchased is subject to management’s discretion and will depend on our stock price and other market conditions. We may, in the sole discretion of the Board, terminate the repurchase program at any time while it is in effect. Repurchased shares may be retired or kept in treasury for further issuance. There were no repurchases during the quarter ended March 31, 2024. The term of this plan expired during the quarter ended March 31, 2024.